This inventor holds 3 USPTO granted patents and 5 published patent applications and 1 EPO patent. Top assignees: Louisiana State University and Agricultural & Mechanical College, Melior Pharmaceuticals I, Inc.. Active years: 2020-2024.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
3 out of 840 
3 out of 13 Years Active: 2020-2024
Title: Ann Coulter: Innovator in Adipocyte Treatment
Introduction
Ann Coulter is a notable inventor based in Baton Rouge, Louisiana. She has made significant contributions to the field of medical treatments, particularly focusing on adipocytes. With a total of 3 patents, her work addresses various metabolic disorders and conditions.
Latest Patents
Coulter's latest patents include innovative compositions that comprise a lyn kinase activator and TRPM8 agonist. These compositions are designed to reduce blood glucose levels, weight gain, and fat depot levels. Additionally, her patents aim to treat metabolic syndrome, obesity, prediabetes, type I and II diabetes, and other related health issues. The methods outlined in her patents also focus on preventing pancreatic beta cell degeneration and inducing the beiging of adipocytes.
Career Highlights
Throughout her career, Ann Coulter has worked with reputable organizations such as Melior Pharmaceuticals Inc. and Louisiana State University and Agricultural & Mechanical College. Her research and inventions have contributed to advancements in the treatment of various metabolic disorders.
Collaborations
Coulter has collaborated with notable individuals in her field, including Andrew G. Reaume and Weina Cong. These partnerships have further enhanced her research and development efforts.
Conclusion
Ann Coulter's innovative work in adipocyte treatment showcases her dedication to improving health outcomes for individuals with metabolic disorders. Her patents reflect a commitment to advancing medical science and providing effective solutions for complex health issues.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile